APA

Yang X., Zhang B., Lu X., Yan M., Wen Y., Zhao T. & Li P. (20170209). Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease. : BMC complementary and alternative medicine.

Chicago

Yang Xin, Zhang Bingxuan, Lu Xiaoguang, Yan Meihua, Wen Yumin, Zhao Tingting and Li Ping. 20170209. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease. : BMC complementary and alternative medicine.

Harvard

Yang X., Zhang B., Lu X., Yan M., Wen Y., Zhao T. and Li P. (20170209). Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease. : BMC complementary and alternative medicine.

MLA

Yang Xin, Zhang Bingxuan, Lu Xiaoguang, Yan Meihua, Wen Yumin, Zhao Tingting and Li Ping. Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease. : BMC complementary and alternative medicine. 20170209.